Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) FCF Margin (2016 - 2020)

Edesa Biotech's FCF Margin history spans 8 years, with the latest figure at 335393.6% for Q3 2020.

  • For Q3 2020, FCF Margin changed N/A year-over-year to 335393.6%; the TTM value through Jun 2021 reached 2998837.8%, down 299717034.0%, while the annual FY2020 figure was 1518.0%, N/A changed from the prior year.
  • FCF Margin for Q3 2020 was 335393.6% at Edesa Biotech, down from 1059.82% in the prior quarter.
  • Across five years, FCF Margin topped out at 629.88% in Q3 2018 and bottomed at 704325.6% in Q2 2019.
  • The 5-year median for FCF Margin is 1747.3% (2018), against an average of 79166.51%.
  • The largest annual shift saw FCF Margin crashed -4248261bps in 2017 before it soared 4297304bps in 2018.
  • A 5-year view of FCF Margin shows it stood at 1021.78% in 2016, then plummeted by -463bps to 5755.99% in 2017, then soared by 111bps to 629.88% in 2018, then plummeted by -216bps to 732.57% in 2019, then crashed by -45683bps to 335393.6% in 2020.
  • Per Business Quant, the three most recent readings for EDSA's FCF Margin are 335393.6% (Q3 2020), 1059.82% (Q1 2020), and 732.57% (Q4 2019).